Global News

Sunovion touts positive results from ADHD pivotal study evaluating dasotraline

Monday, April 24, 2017

Sunovion Pharmaceuticals announced positive results of a pivotal phase III study (SEP360-305) evaluating the efficacy and safety of novel drug candidate dasotraline, a dopamine and norepinephrine reuptake inhibitor (DNRI) being evaluated in children 6 to 12 years of age with attention deficit hyperactivity disorder (ADHD). In a laboratory classroom setting, dasotraline showed persistent, statistically significant improvement in ADHD symptoms compared to placebo throughout the day (12 to 24 hours post-dose), demonstrating a duration of effect of up to 24 hours, and was generally well-tolerated.

[Read More]

DHL acquires Polar Transportes for Latin America service coverage

Monday, April 24, 2017

DHL Supply Chain, the contract logistics specialist within Deutsche Post DHL Group, is to acquire control of the Brazilian road carrier Polar Transportes, retaining the company’s management team. The transport service provider for the Life Sciences and Healthcare industry with 400 full-time employees is specialized in temperature-controlled transportation requirements and has a strong reputation in terms of technology, quality and regulatory compliance.

[Read More]

Metrion Biosciences, Venomtech partner

Monday, April 24, 2017

Metrion Biosciences, a specialist ion channel CRO and drug discovery company, and Venomtech, a U.K. biotechnology company with a venom library, announced a collaboration agreement that will see the two companies combine their resources and expertise to search for novel ion channel modulators for use in drug discovery research.

[Read More]

Social media tips for research sites

Monday, April 24, 2017

The Pulse on Site Success by Christophe Berthoux

When sites are juggling multiple studies, it can be easy to push social media efforts to the backseat. However, this may deter from opportunities to expand clinical trial awareness and potentially bringing new business to sites. Fortunately, a site can implement tools and processes to allow for social media interaction, while maintaining the balance between keeping up with administrative workloads and providing patient care.

[Read More]

SynteractHCR adds three senior executives to management team

Thursday, April 20, 2017

SynteractHCR, a full-service, international CRO, has appointed three new senior-level managers to its leadership team to ensure internationally-cohesive, enhanced support for sponsors. SynteractHCR’s newest senior executives include: Heather Davis, executive director of U.S. Project Management; Zia Haque, executive director, Clinical Data Management, and John Whitaker, Ph.D. as executive director, Biostatistics. All will report to Marlo M. Vasquez, vice president, U.S. Operations at SynteractHCR.

[Read More]

Plasticell, Kings College London to collaborate in blood platelet substitute trials

Thursday, April 20, 2017

Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, has partnered with King’s College London to progress preclinical trials of its artificial blood platelet product, manufactured from pluripotent stem cells. The work is supported by a MedCity research grant which funds collaboration between leading SMEs and academics from London universities.

[Read More]